AtriCure (ATRC) Net Cash Flow (2016 - 2025)
AtriCure (ATRC) has disclosed Net Cash Flow for 16 consecutive years, with $19.5 million as the latest value for Q4 2025.
- Quarterly Net Cash Flow rose 374.24% to $19.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $44.0 million through Dec 2025, up 13.2% year-over-year, with the annual reading at $44.0 million for FY2025, 13.2% up from the prior year.
- Net Cash Flow for Q4 2025 was $19.5 million at AtriCure, down from $30.1 million in the prior quarter.
- The five-year high for Net Cash Flow was $43.6 million in Q1 2021, with the low at -$27.6 million in Q3 2021.
- Average Net Cash Flow over 5 years is $6.3 million, with a median of $6.5 million recorded in 2021.
- The sharpest move saw Net Cash Flow soared 761.06% in 2021, then plummeted 297.59% in 2024.
- Over 5 years, Net Cash Flow stood at $3.9 million in 2021, then surged by 132.43% to $9.0 million in 2022, then plummeted by 60.1% to $3.6 million in 2023, then tumbled by 297.59% to -$7.1 million in 2024, then surged by 374.24% to $19.5 million in 2025.
- According to Business Quant data, Net Cash Flow over the past three periods came in at $19.5 million, $30.1 million, and $17.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.